Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001913491-25-000001
Filing Date
2025-06-11
Accepted
2025-06-11 08:02:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3082
  Complete submission text file 0001913491-25-000001.txt   4575
Mailing Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130
Business Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Subject) CIK: 0001835268 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40212 | Film No.: 251038814
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CONNECT BIOPHARMA HOLDINGS LTD SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL 6 BEIJING WEST ROAD, TAICANG F4 215400
Business Address
Wei Zheng (Reporting) CIK: 0001913491 (see all company filings)

Type: 144